+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

From
Uveitic Glaucoma - Pipeline Insight, 2025 - Product Thumbnail Image

Uveitic Glaucoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Zollinger Ellison Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Zollinger Ellison Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Hyperlipidemia - Pipeline Insight, 2025 - Product Thumbnail Image

Hyperlipidemia - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Mucopolysaccharidosis - Pipeline Insight, 2025 - Product Thumbnail Image

Mucopolysaccharidosis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
5-HT2B Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

5-HT2B Antagonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
5-HT6 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

5-HT6 Antagonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
5-HT7 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

5-HT7 Antagonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Hypereosinophilic Syndrome- Pipeline Insight, 2025 - Product Thumbnail Image

Hypereosinophilic Syndrome- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Dengue- Pipeline Insight, 2025 - Product Thumbnail Image

Dengue- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Chronic Plaque Psoriasis - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Plaque Psoriasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Chikungunya - Pipeline Insight, 2025 - Product Thumbnail Image

Chikungunya - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Bipolar Disorder (Manic Depression)- Pipeline Insight, 2025 - Product Thumbnail Image

Bipolar Disorder (Manic Depression)- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Wet Macular Degeneration - Pipeline Insight, 2025 - Product Thumbnail Image

Wet Macular Degeneration - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Insight, 2025 - Product Thumbnail Image

Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) - Pipeline Insight, 2025 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Alcohol Addiction - Pipeline Insight, 2025 - Product Thumbnail Image

Alcohol Addiction - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Acute Lung Injury - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Lung Injury - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more